<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li J</submitter><funding>NIDCD NIH HHS</funding><pagination>22382</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11437005</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Cisplatin is a commonly used chemotherapy agent with a nearly universal side effect of sensorineural hearing loss. The cellular mechanisms underlying cisplatin ototoxicity are poorly understood. Efforts in drug development to prevent or reverse cisplatin ototoxicity have largely focused on pathways of oxidative stress and apoptosis. An effective treatment for cisplatin ototoxicity, sodium thiosulfate (STS), while beneficial when used in standard risk hepatoblastoma, is associated with reduced survival in disseminated pediatric malignancy, highlighting the need for more specific drugs without potential tumor protective effects. The unfolded protein response (UPR) and endoplasmic reticulum (ER) stress pathways have been shown to be involved in the pathogenesis of noise-induced hearing loss a</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Modulating the unfolded protein response with ISRIB mitigates cisplatin ototoxicity.</pubmed_title><pmcid>PMC11437005</pmcid><funding_grant_id>DC018583-01</funding_grant_id><funding_grant_id>R01 DC018583</funding_grant_id><pubmed_authors>Rouse SL</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Park Y</pubmed_authors><pubmed_authors>Matthews IR</pubmed_authors><pubmed_authors>Eltawil Y</pubmed_authors><pubmed_authors>Chan DK</pubmed_authors><pubmed_authors>Sherr EH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Modulating the unfolded protein response with ISRIB mitigates cisplatin ototoxicity.</name><description>Cisplatin is a commonly used chemotherapy agent with a nearly universal side effect of sensorineural hearing loss. The cellular mechanisms underlying cisplatin ototoxicity are poorly understood. Efforts in drug development to prevent or reverse cisplatin ototoxicity have largely focused on pathways of oxidative stress and apoptosis. An effective treatment for cisplatin ototoxicity, sodium thiosulfate (STS), while beneficial when used in standard risk hepatoblastoma, is associated with reduced survival in disseminated pediatric malignancy, highlighting the need for more specific drugs without potential tumor protective effects. The unfolded protein response (UPR) and endoplasmic reticulum (ER) stress pathways have been shown to be involved in the pathogenesis of noise-induced hearing loss a</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep</publication><modification>2025-04-03T23:49:56.511Z</modification><creation>2025-04-03T23:49:56.511Z</creation></dates><accession>S-EPMC11437005</accession><cross_references><pubmed>39333235</pubmed><doi>10.1038/s41598-024-70561-w</doi></cross_references></HashMap>